RBC Capital lowered the firm’s price target on Biogen (BIIB) to $225 from $231 but keeps an Outperform rating on the shares after its Q4 ...

RBC Capital Markets reiterated its Outperform rating on Adobe (NASDAQ:ADBE) stock with a steadfast price target of $590.00, ...

The prospect of a growing trade war isn’t just a risk to Canada’s industries, it also poses a threat to the Canadian housing market, says RBC Economics.

Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning, ladies and gentlemen, and welcome to Brighthouse ...

CEO Eric Steigerwalt highlighted 2024 as a year of both achievements and challenges. He emphasized the company's progress on strategic initiatives aimed at improving capital efficiency and maintaining ...

Changes associated with anemia tongue are called glossitis, otherwise known as tongue inflammation. This article explains why ...

On the back of US contract wins, home-grown radiology giant Pro Medicus reports a record December half with the promise of ...

FY2025 revenue guidance was raised to a range of $1.5 billion to $1.575 billion, up from the previous range of $1.425 billion to $1.525 billion, driven by strong Medicare Advantage and SelectRx ...

RBC, Jefferies and BNP Paribas are well placed to make gains as HSBC retrenches after Deutsche Numis shows momentum ...

IN a recent paper, Dervichian, Fournet and Guinier describe experiments on the low-angle scattering of X-rays from red blood cells 1. They show that the scattering curve can be explained as being ...

TipRanks’ analyst ranking service spotlights three dividend-paying stocks, including International Business Machines and ...